Drug Delivery Business2h
Tandem Diabetes Care introduces next-gen automated insulin delivery algorithm
Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...
Drug Delivery Business5h
Tandem has positive data for automated insulin delivery in type 2 diabetes population
Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...
Drug Delivery Business7h
Dexcom study finds that providers prefer tech over medication for type 2 diabetes
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.
Drug Delivery Business6h
Dexcom CGM now connects with Novo Nordisk smart insulin pens, 15-day CGM shows promise
Dexcom (Nadsaq:DXCM) today announced new insulin delivery integrations and updates on enhanced continuous glucose monitors ...
Drug Delivery Business1d
Insulet expands Omnipod 5 to more countries, prices $450M offering
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...
Drug Delivery Business1d
Insulet CTO Mark Field departs for new opportunities
Insulet (Nasdaq:PODD) announced today that SVP and Chief Technology Officer Mark Field is departing the company.
Drug Delivery Business1d
Ypsomed, CamDiab launch iOS app for automated insulin delivery system
Ypsomed and CamDiab today announced the launch of the mylife CamAPS FX app for automated insulin delivery on iOS platforms.
Drug Delivery Business1d
Sequel Med Tech makes first CGM integration with Abbott for automated insulin pump
Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.
Drug Delivery Business6d
Vivani reports first human GLP-1 implant for weight loss in adults
Vivani Medical (Nasdaq:VANI) announced today that it successfully administered the first GLP-1 implant in its LIBERATE-1 ...
Drug Delivery Business6d
Trinity Biotech to undergo strategic realignment, focus on CGM development
Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.
drugdeliverybusiness7d
Vivani to spin out neurostim business, focus on GLP-1 implant
Vivani Medical (Nasdaq:VANI) announced today that it plans to spin off Cortigent, a division that develops brain implants. The company wants to create two focused companies dedicated to driving ...